Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03743285 · ClinicalTrials.gov registry record · NA
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)
A NA study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03743285 is a NA study that has completed, run by Eli Lilly and Company. The registered enrollment target is 10 participants.
The verdict
NCT03743285, a NA study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system and to test whether the AID System functions as designed. The study will last about 3 months with up to 6 days of inpatient time.
Interventions
- DEVICE AID System
- DRUG Insulin Lispro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2019-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03743285
The ClinicalTrials.gov registry entry for NCT03743285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AID System is the first listed.
NCT03743285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03743285 about?
NCT03743285 is a clinical study titled "A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)". The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system and to test whether the AID System functions as designed. The study will last about 3 ...
What is the current status of trial NCT03743285?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-11-14. Estimated completion is 2019-01-28.
What interventions are being tested in trial NCT03743285?
The interventions under investigation include: AID System (DEVICE), Insulin Lispro (DRUG).
Who is sponsoring clinical trial NCT03743285?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.